+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Amgen Inc. - logo

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

Oncology Biosimilars Market - Global Forecast 2026-2032 - Product Thumbnail Image

Oncology Biosimilars Market - Global Forecast 2026-2032

  • Report
  • August 2026
  • 194 Pages
  • Global
From
From
Lung Cancer Therapeutics Market - Global Forecast 2026-2032 - Product Thumbnail Image

Lung Cancer Therapeutics Market - Global Forecast 2026-2032

  • Report
  • August 2026
  • 183 Pages
  • Global
From
Lung Cancer Drugs Market - Global Forecast 2026-2032 - Product Thumbnail Image

Lung Cancer Drugs Market - Global Forecast 2026-2032

  • Report
  • August 2026
  • 199 Pages
  • Global
From
From
From
From
From
Bioengineered Protein Drugs Market - Global Forecast 2026-2032 - Product Thumbnail Image

Bioengineered Protein Drugs Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 196 Pages
  • Global
From
Schizophrenia Market Report 2026 - Product Thumbnail Image

Schizophrenia Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
From
From
From
From
Immunology Collaboration and Licensing Deals 2018-2026 - Product Thumbnail Image

Immunology Collaboration and Licensing Deals 2018-2026

  • Report
  • April 2026
  • 450 Pages
  • Global
From
Biosimilars Market Report 2026 - Product Thumbnail Image

Biosimilars Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Loading Indicator